Abstract
Background: Splenic artery aneurysms are uncommon even though they are second only to those of the aorto-iliac system. There is also controversy regarding their management. Methods: We report the case of a 50-year-old patient with ruptured splenic artery aneurysm and review the literature regarding its diagnosis and management. Results: The patient underwent emergency laparotomy and splenectomy was performed. Conclusion: Resuscitation and an aggressive surgical approach should be taken in order to save the life of the patients.
References
1.
Hohn DC: Aneurysm of the splenic artery; in Way LW (ed): Current Surgical Diagnosis and Treatment. New York, Lange, 1990, pp 1–595.
2.
Trastek VF, Pairolero PC, Joyce JW, Hollier LH, Bernatz PE: Splenic artery aneurysms. Surgery 1982;91:694–699.
3.
Stanley JC, Fry WJ: Pathogenesis and clinical significance of splenic artery aneurysms. Surgery 1974;76:898–909.
4.
De Vries JE, Schattenkerk ME, Malt RA: Complications of splenic artery aneurysm other than intraperitoneal rupture. Surgery 1982;91:200–204.
5.
Mattar SG, Lumsden AB: The management of splenic artery aneurysms: Experience with 23 cases. Am J Surg 1995;169:580–584.
6.
Woods MS, Traverso LW, Kozarek RA, Brandabur J, Hauptmann E: Successful treatment of bleeding pseudoaneurysms of chronic pancreatitis. Pancreas 1995;10:22–30.
7.
El Hamel A, Parc R, Adda G, Bouteloup PY, Huguet C, Malafosse M: Bleeding pseudocysts and pseudoaneurysms in chronic pancreatitis. Br J Surg 1991;78:1059–1063.
8.
Babb RR: Aneurysm of the splenic artery. Arch Surg 1976;111:924–925.
9.
Jones EL, Finney GG Jr: Splenic artery aneurysms, a reappraisal. Arch Surg 1968;97:640–647.
10.
Bedford PD, Lodge B: Aneurysm of the splenic artery. Gut 1960;1:312–320.
11.
Caillouette JC, Merchant EB: Ruptured splenic artery aneurysm in pregnancy, twelfth reported case with maternal and fetal survival. Am J Obstet Gynecol 1993;168:1810–1813.
12.
Holdsworth RJ, Gunn A: Ruptured splenic artery aneurysm in pregnancy. A review. Br J Obstet Gynaecol 1992;99:595–597.
13.
Ayalon A, Wiesner RH, Perkins JD, Tominaga S, Hayes DH, Krom RA: Splenic artery aneurysms in liver transplant patients. Transplantation 1988;45:386–389.
14.
Salo JA, Salmenkivi K, Tenhunen A, Kivilaakso EO: Rupture of splanchnic artery aneurysms in liver transplant patients. World J Surg 1986;10:123–127.
15.
Owens JC, Coffey RJ: Aneurysm of the splenic artery, including a report of 6 additional cases. Int Abstr Surg 1953;97:313–335.
16.
Camishion RC, Pello MJ, Spence RK, Alexander JB, Atabek UM, Kuroda K: Hemoductal pancreatitis. Surgery 1992;111:86–89.
17.
Cahow CE, Gusberg RJ, Gottlieb LJ: Gastrointestinal hemorrhage from pseudoaneurysms in pancreatic pseudocysts. Am J Surg 1983;145:534–541.
18.
Clay RP, Farnell MB, Lancester JR, Weiland LH, Gostout CJ: Hemosuccus pancreaticus. An unusual cause of upper gastrointestinal bleeding. Ann Surg 1985;202:75–79.
19.
Trastek VF, Pairolero PC, Bernatz PE: Splenic artery aneurysms. World J Surg 1985;9:378–383.
20.
de Perrot M, Buhler L, Deléaval J, Borisch B, Mentha G, Morel P: Management of true aneurysms of the splenic artery. Am J Surg 1998;175:466–468.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.